Phase I/II Trial: BIBF 1120 Added to Low-dose Cytarabine in Elderly Patients With Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
HLA-mismatched Microtransplantation for High Risk Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE3
ALT-801-activated Natural Killer Cells After FLAG Induction for Acute Myeloid Leukemia
- Status
- WITHDRAWN
- Phase
- PHASE1
Protocol in Acute Myeloid Leukemia With FLT3-ITD
- Status
- COMPLETED
- Phase
- PHASE2
Study of OCV-501 in Patients With Acute Myeloid Leukemia (AML) (Extension From Study 311-10-001)
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Dose Finding and Proof-of-concept Study of Panobinostat With Standard Dose Cytarabine and Daunorubicin for Untreated Acute Myeloid Leukemia or Advanced Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
PRO#0118: Decitabine Plus Mini Flu-Bu
- Status
- COMPLETED
- Phase
- PHASE1
Study in Plerixafor and Granulocyte-colony Stimulating Factor Patients With Relapse Acute Myeloid Leukemia
- Status
- TERMINATED
- Phase
- PHASE1
Risk-adapted, MRD-directed Therapy for Young Adults With Newly Diagnosed Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Phase I/II Study With Oral Panobinostat Maintenance Therapy Following Allogeneic Stem Cell Transplantation in Patients With High Risk Myelodysplastic Syndrome (MDS) or Acute Myeloid Leukemia (AML)
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
An Exercise Trial for Acute Myeloid Leukaemia (AML) Patients Undergoing Induction Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
A Phase I Study of OCV-501 in Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE1
Study of Lenalidomide in Patients With Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- Status
- COMPLETED
- Phase
- PHASE1
ClAraC or FLAMSA Followed by Stem Cell Transplantation to Treat High Risk AML or Advanced MDS
- Status
- UNKNOWN
- Phase
- PHASE2
Decitabine With or Without Bortezomib in Treating Older Patients With Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Study of BMN 673, a PARP Inhibitor, in Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Sorafenib Maintenance Therapy for Patients With AML After Allogeneic Stem Cell Transplant
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Clinical Study of CWP232291 in Acute Myeloid Leukemia Patients
- Status
- COMPLETED
- Phase
- PHASE1
MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia
- Status
- COMPLETED
- Phase
- N/A